Robert Carey Insider Profile

11 Followers
Robert Carey, Director at Argos Therapeutics, holds 1.48M shares in Beyond Air (Ticker: XAIR), holds 74.60K shares in Sangamo Biosciences (Ticker: SGMO), holds 266.36K shares in Horizon Therapeutics (Ticker: HZNP). Most recently, Robert Carey Bought ― shares of Beyond Air on Oct 01, 2024 for an estimated value of 738.31K.
tipranks
Robert Carey

Robert Carey
Argos Therapeutics (ARGSQ)
Director

Ranked #93,736 out of 99,218 Corporate Insiders

Profitable Transactions

41%
11 out of 27 Profitable Transactions

Average Return

-22.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$839K
84.52%
15.48%
A breakdown of Robert Carey's holdings

Insider Roles

Beyond Air
(XAIR)
Director
Sangamo Biosciences
(SGMO)
Director
Roles that Robert Carey holds in companies

Most Profitable Insider Trade

Stock:
Beyond Air
(XAIR)
Rating:Informative Buy
Date:Aug 26, 2020 - Aug 26, 2021
Return:+76.10%
The most profitable trade made by Robert Carey

Robert Carey's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ARGSQ
Argos Therapeutics
Jan 04, 2017
Uninformative Buy
Sangamo Biosciences
Jun 06, 2024
Director
Uninformative Buy
$129.80K
Beyond Air
Oct 01, 2024
Director
Informative Buy
738.31K
$708.78K
HZNP
Horizon Therapeutics
Feb 22, 2019
Uninformative Buy
$30.98M
List of latest transactions for each holding click on a transaction to see Robert Carey's performance on stock

Robert Carey insider profile FAQ

What is the percentage of profitable transactions made by Robert Carey?
The percentage of profitable transactions made by Robert Carey is 41%.
    What is the average return per transaction made by Robert Carey?
    The average return per transaction made by Robert Carey is -22.80%.
      What stocks does Robert Carey hold?
      Robert Carey holds: ARGSQ, SGMO, XAIR, HZNP stocks.
        What was Robert Carey’s latest transaction?
        Robert Carey latest transaction was an Informative Buy of $738.31K.
          What was Robert Carey's most profitable transaction?
          Robert Carey’s most profitable transaction was an Informative Buy of XAIR stock on August 26, 2020. The return on the trade was 76.10%.
            What is Robert Carey's role in Argos Therapeutics?
            Robert Carey's role in Argos Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.